We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
RegeneCure Starts Worldwide Veterinary Distribution of BoneCure Membrane Implant
News

RegeneCure Starts Worldwide Veterinary Distribution of BoneCure Membrane Implant

RegeneCure Starts Worldwide Veterinary Distribution of BoneCure Membrane Implant
News

RegeneCure Starts Worldwide Veterinary Distribution of BoneCure Membrane Implant

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "RegeneCure Starts Worldwide Veterinary Distribution of BoneCure Membrane Implant"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

RegeneCure Ltd. has announced that the company has started to distribute its BoneCure® Membrane product to the veterinary market around the world.

The distribution follows the successful results of a recent clinical study in several EC countries and Israel. BoneCure Membrane was used by European Veterinary Surgeons in pets for the following indications: non-union, large bone gaps, arthrodesis and severe fractures.

The study showed that the healing time was about 40 percent quicker than normally observed using current Standard of Care therapies.

"Based on the outstanding safety and efficacy results of our clinical and pre-clinical studies, we expect BoneCure to enable veterinary surgeons to treat a larger number of severe fracture types and to significantly reduce the healing time and complication rate," said Moshe Tzabari, CEO of RegeneCure.

Distribution with dealers is now underway throughout Europe, Asia, Australia and the United States.

The use of the BoneCure Membrane for carpal arthrodesis is a major breakthrough in the surgery of companion animals that offers many advantages over the traditional “Gold Standard” procedure of harvesting an autogenous bone graft.

This procedure, described at the BoneCure website, prevents patient morbidity and pain, reduces the risks of infection and fracture at the donor site, saves operating time and eliminates the need for a second incision.

Advertisement